Macrogenics, Inc. · NASDAQ:MGNX
Frazier Life Sciences Public Fund, L.P. reported a 2.50% stake in Macrogenics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Frazier Life Sciences Public Fund, L.P. reported a 2.50% stake in Macrogenics, Inc., 1,549,193 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 2.50%
- Shares
- 1,549,193
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 17 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 2.50% | 1,549,193 |
| FHMLSP, L.P. | 2.50% | 1,549,193 |
| FHMLSP, L.L.C. | 2.50% | 1,549,193 |
| Frazier Life Sciences Public Overage Fund, L.P. | 1.50% | 925,809 |
| FHMLSP Overage, L.P. | 1.50% | 925,809 |
| FHMLSP Overage, L.L.C. | 1.50% | 925,809 |
| Frazier Life Sciences X, L.P. | 0.20% | 125,513 |
| FHMLS X, L.P. | 0.20% | 125,513 |
| FHMLS X, L.L.C. | 0.20% | 125,513 |
| Frazier Life Sciences XI, L.P. | 0.90% | 575,150 |
| FHMLS XI, L.P. | 0.90% | 575,150 |
| FHMLS XI, L.L.C. | 0.90% | 575,150 |
| James N. Topper | 0.20% | 125,513 |
| Patrick J. Heron | 0.20% | 125,513 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Macrogenics, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Macrogenics, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Feb 13, 2026
- Form 4 · Bonvini Ezio · Oct 7, 2026
- Form 4 · Peters Jeffrey Stuart · Aug 20, 2026
- Form 4 · Bonvini Ezio · Aug 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Bank of America Corp · Aug 3, 2026